HLTRF Stock Price, Chart, Stats & News

HLS Therapeutics Inc.
Save
HLS Therapeutics Inc. (HLTRF) does not currently pay a dividend.
–
Market cap
–
Current P/E
31.95x
Forward P/E
HLTRF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry
HLS Therapeutics Inc. is a specialized pharmaceutical firm engaged in the acquisition and commercialization of medicinal products, with a primary focus on the central nervous system (CNS) and cardiovascular (CV) therapeutic areas. The company's activities extend across Canada, the United States, and international territories. Its core product lineup features Clozaril, an atypical antipsychotic medication prescribed for schizophrenia; Vascepa, composed of icosapent ethyl capsules; and PERSERIS, an injectable risperidone formulation also employed in the treatment of schizophrenia.
Similar securities
Based on sector and market capitalization
Report issue





